Compounds > hippocampal cholinergic neurostimulating peptide
Page last updated: 2024-08-25

hippocampal cholinergic neurostimulating peptide and Alzheimer Disease

hippocampal cholinergic neurostimulating peptide has been researched along with Alzheimer Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borlongan, CV; Haji, A; Kanamori, T; Kato, D; Matsukawa, N; Mizuno, M; Ohi, Y; Sato, T; Takase, H1
Matsukawa, N1
Akatsu, H; Borlongan, CV; Hattori, M; Katada, E; Maki, M; Matsukawa, N; Nakazawa, H; Ojika, K; Okita, K1
Matsukawa, N; Ojika, K1
Fujimori, O; Katada, E; Matsukawa, N; Mitake, S; Ojika, K; Otsuka, Y1
Fujimori, O; Iwase, T; Katada, E; Matsukawa, N; Mitake, S; Ojika, K; Otsuka, Y; Tsugu, T1
Hirano, A; Mitake, S; Ojika, K1

Reviews

2 review(s) available for hippocampal cholinergic neurostimulating peptide and Alzheimer Disease

ArticleYear
[The involvement of hippocampal cholinergic neurostimulating peptide and its precursor in Alzheimer pathogenesis].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2014, Volume: 34, Issue:3

    Topics: Alzheimer Disease; Animals; Bipolar Disorder; Mice; Mice, Transgenic; Neuropeptides

2014
Hirano bodies and Alzheimer's disease.
    The Kaohsiung journal of medical sciences, 1997, Volume: 13, Issue:1

    Topics: Alzheimer Disease; Hippocampus; Humans; Immunohistochemistry; Inclusion Bodies; Neuropeptides

1997

Other Studies

5 other study(ies) available for hippocampal cholinergic neurostimulating peptide and Alzheimer Disease

ArticleYear
Hippocampal Cholinergic Neurostimulating Peptide as a Possible Modulating Factor against Glutamatergic Neuronal Disability by Amyloid Oligomers.
    Cell transplantation, 2017, Volume: 26, Issue:9

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Dopaminergic Neurons; Electrophysiology; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Neuropeptides

2017
Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.
    Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2

    Topics: Aged; Alzheimer Disease; Base Sequence; CpG Islands; DNA; Enhancer Elements, Genetic; Female; Gene Expression; Genetic Variation; Humans; Male; Molecular Sequence Data; Mutation; Neurons; Neuropeptides; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Sequence Analysis, DNA

2009
[Function of HCNP/HCNP precursor in memory formation].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2006, Volume: 26, Issue:5-6

    Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Humans; Memory; Neuropeptides; Phosphatidylethanolamine Binding Protein; Phosphorylation; Rats; Receptors, N-Methyl-D-Aspartate; Septal Nuclei; tau Proteins

2006
Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies.
    Neuropathology and applied neurobiology, 1995, Volume: 21, Issue:1

    Topics: Aged; Alzheimer Disease; Cholinergic Agents; Female; Hippocampus; Humans; Immunohistochemistry; Inclusion Bodies; Male; Microscopy, Immunoelectron; Middle Aged; Neuropeptides; Paraffin Embedding; Parasympathetic Nervous System; Spinal Cord

1995
Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano body formation.
    Neuropathology and applied neurobiology, 1996, Volume: 22, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Hippocampus; Humans; Immunohistochemistry; Inclusion Bodies; Male; Microscopy, Immunoelectron; Nerve Tissue Proteins; Neurofibrillary Tangles; Neuropeptides

1996